FDA Recall Terminated

IMMULITE 2000/IMMULITE 2000 XPi Anti HBc

Recall: Z-1675-2018 · Initiated January 2, 2018

Recall

Recall Number
Z-1675-2018
Event Number
79505
Firm
Siemens Healthcare Diagnostics, Inc.
FEI Number
2432235
Product Code
LOM
Status
Terminated
Root Cause
Error in labeling
Initiated
January 2, 2018
Posted
May 4, 2018
Terminated
February 10, 2023
Address
511 Benedict Ave, Tarrytown, NY, 10591-5005

Description

IMMULITE 2000/IMMULITE 2000 XPi Anti HBc

Reason

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

Action

Siemens Healthcare Diagnostics issued a recall in March 2017 for products with incorrect units for biotin in the Instructions for Use. After further investigation, recalling firm determined that more Siemens products also had missing or incorrect information in the IFUs for which two recalls were initiated, and Amended Corrections and Removals Reports were submitted to the FDA

Distribution

Nationwide and Canada, Mexico, and Thailand